PTCH1 and neoplasm: OKC was classified as a tumor by the World Health Organization from 2005 to 2017 because of its high relapse rate, invasiveness, presence of epithelial dysplasia, and the recognition of gene mutations in tumor markers such as PTCH1 and Ki-67 [5–7].